InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
4.940
-0.060 (-1.20%)
Apr 25, 2025, 4:00 PM EDT - Market closed
InfuSystem Holdings Revenue
In the year 2024, InfuSystem Holdings had annual revenue of $134.86M with 7.22% growth. InfuSystem Holdings had revenue of $33.85M in the quarter ending December 31, 2024, with 6.54% growth.
Revenue (ttm)
$134.86M
Revenue Growth
+7.22%
P/S Ratio
0.79
Revenue / Employee
$262,375
Employees
514
Market Cap
103.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 134.86M | 9.08M | 7.22% |
Dec 31, 2023 | 125.79M | 15.87M | 14.44% |
Dec 31, 2022 | 109.91M | 7.53M | 7.36% |
Dec 31, 2021 | 102.38M | 5.79M | 5.99% |
Dec 31, 2020 | 96.60M | 15.52M | 19.14% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.90B |
INFU News
- 25 days ago - InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer - Business Wire
- 7 weeks ago - InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024 - Business Wire
- 2 months ago - InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Business Wire
- 2 months ago - InfuSystem Set For Strong Year - Seeking Alpha
- 5 months ago - InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024 - Business Wire
- 5 months ago - InfuSystem Appoints Ronald Hundzinski to the Board of Directors - Business Wire
- 5 months ago - InfuSystem Holdings, Inc. (INFU) Q3 2024 Earnings Call Transcript - Seeking Alpha